The Reserpine Injection, cataloged under National Stock Number 6505-00-616-8955, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Ciba-Geigy Corp Ciba Pharmaceuticals Div. Government technical data includes 5 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-00-616-8955 |
| Primary Part Number | NDC00083-7642-05 |
| Item Name | Reserpine Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Ciba-Geigy Corp Ciba Pharmaceuticals Div |
| Status | ACTIVE |
| Primary Container Content Quantity | 2.000 MILLILITERS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | AMPUL |
| Active Medicament Medicinal Strength | 2.500 MILLIGRAMS RESERPINE PER MILLILITER |
| Total Primary Container Quantity | 5 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| NDC00083-7642-05 PRIMARY | Ciba-Geigy Corp Ciba Pharmaceuticals Div (USA) |
| Reference | Meaning |
|---|---|
| SERPASIL | 5/1 Secondary reference Ciba-Geigy Corp Ciba Pharmaceuticals Div |
NSN 6505-00-616-8955 is a Reserpine Injection, manufactured by Ciba-Geigy Corp Ciba Pharmaceuticals Div, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-00-616-8955 has 1 manufacturer part number on file: NDC00083-7642-05 (Ciba-Geigy Corp Ciba Pharmaceuticals Div).
Key specifications for NDC00083-7642-05: Primary Container Content Quantity: 2.000 MILLILITERS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: AMPUL; Active Medicament Medicinal Strength: 2.500 MILLIGRAMS RESERPINE PER MILLILITER. 5 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.